Correlation Between Pmv Pharmaceuticals and Icosavax
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Icosavax, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Icosavax.
Diversification Opportunities for Pmv Pharmaceuticals and Icosavax
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pmv and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Icosavax go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Icosavax
If you would invest (100.00) in Icosavax on December 28, 2024 and sell it today you would earn a total of 100.00 from holding Icosavax or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Pmv Pharmaceuticals vs. Icosavax
Performance |
Timeline |
Pmv Pharmaceuticals |
Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Pmv Pharmaceuticals and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pmv Pharmaceuticals and Icosavax
The main advantage of trading using opposite Pmv Pharmaceuticals and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |